CySEC Withdraws Conotoxia Ltd Licence

The Cyprus Securities and Exchange Commission has withdrawn the Cyprus Investment Firm authorisation of Conotoxia Ltd, ending the companys regulated investment services status in Cyprus.

Conotoxia Ltd previously operated as the investment services arm of the wider Conotoxia group. Its trading offering included contracts for difference across multiple asset classes, including forex, stocks, indices, commodities, ETFs, futures, and other instruments.

Licence withdrawn after earlier suspension

CySEC said the withdrawal decision followed the companys failure to meet ongoing authorisation requirements under Cyprus investment services rules.

The regulator pointed to several deficiencies, including the suitability of a board member, the requirement to have at least two persons effectively directing the business, the suitability of a shareholder, and the companys organisational arrangements.

Based on these issues, CySEC concluded that Conotoxia Ltd no longer fulfilled the conditions under which its authorisation had originally been granted.

Company ordered to remove licence references

Following the withdrawal, CySEC instructed Conotoxia Ltd to immediately remove references to investment services, its CySEC licence, and CySEC supervision from its websites and other public materials.

The company was also told not to provide investment or ancillary services after the withdrawal of its authorisation.

In addition, CySEC ordered Conotoxia Ltd to investigate and resolve customer complaints submitted to the company.

Earlier enforcement action set the background

The licence withdrawal came after an earlier suspension of Conotoxia Ltd‘s authorisation. The company’s licence had already been suspended since July last year before the regulator moved to full withdrawal.

The case means Conotoxia Ltd can no longer rely on its former Cyprus Investment Firm status to provide regulated investment services.

Wider group developments remain under scrutiny

The licence decision also comes at a time when parts of the broader Conotoxia-related group structure have faced regulatory and legal attention in Poland.

Recent Polish proceedings involving related entities have added further context around the groups operations, including allegations linked to client losses and frozen accounts. These matters are separate from the CySEC licence withdrawal, but they add to the wider public scrutiny surrounding the group.

What the withdrawal means

The key point is straightforward: Conotoxia Ltd no longer holds its CySEC investment firm authorisation.

Any website, document, or communication suggesting that the company is still authorised by CySEC for investment services would need to be reviewed against the updated licence status. For clients and market participants, the main issues to check are the current legal entity, active licence status, permitted services, and any pending complaint-handling arrangements.

About WikiFX

WikiFX is a global broker information platform that provides broker profiles, licence records, regulatory updates, risk alerts, and user exposure data to help users review a platforms public compliance background.